Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mailuo Shutong Pills for Diabetic Wounds
NCT07258381Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- HM (Herbal Medicine)
01
Overview
Randomised trial of mailuoshutong in diabetic foot ulcer (DFU) (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Wound area reduction rate at 14 days. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
mailuoshutong
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT07258381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07258381.